These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37941596)

  • 21. Rac1 as a Potential Pharmacodynamic Biomarker for Thiopurine Therapy in Inflammatory Bowel Disease.
    Seinen ML; van Nieuw Amerongen GP; de Boer NK; Mulder CJ; van Bezu J; van Bodegraven AA
    Ther Drug Monit; 2016 Oct; 38(5):621-7. PubMed ID: 27465973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adverse Events of Thiopurine Therapy in Pediatric Inflammatory Bowel Disease and Correlations with Metabolites: A Cohort Study.
    Jagt JZ; Pothof CD; Buiter HJC; van Limbergen JE; van Wijk MP; Benninga MA; de Boer NKH; de Meij TGJ
    Dig Dis Sci; 2022 Jan; 67(1):241-251. PubMed ID: 33532972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-TNF and thiopurine therapy in pregnant IBD patients does not significantly alter a panel of B-cell and T-cell subsets in 1-year-old infants.
    Kattah MG; Milush JM; Burt T; McCabe RP; Whang MI; Ma A; Mahadevan U
    Clin Transl Gastroenterol; 2018 Apr; 9(4):143. PubMed ID: 29618720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Do Thiopurines Reduce the Risk of Surgery in Elderly Onset Inflammatory Bowel Disease? A 20-Year National Population-Based Cohort Study.
    Alexakis C; Saxena S; Chhaya V; Cecil E; Curcin V; Pollok R
    Inflamm Bowel Dis; 2017 Apr; 23(4):672-680. PubMed ID: 28151735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of Genetic Variants in NUDT15 With Thiopurine-Induced Myelosuppression in Patients With Inflammatory Bowel Disease.
    Walker GJ; Harrison JW; Heap GA; Voskuil MD; Andersen V; Anderson CA; Ananthakrishnan AN; Barrett JC; Beaugerie L; Bewshea CM; Cole AT; Cummings FR; Daly MJ; Ellul P; Fedorak RN; Festen EAM; Florin TH; Gaya DR; Halfvarson J; Hart AL; Heerasing NM; Hendy P; Irving PM; Jones SE; Koskela J; Lindsay JO; Mansfield JC; McGovern D; Parkes M; Pollok RCG; Ramakrishnan S; Rampton DS; Rivas MA; Russell RK; Schultz M; Sebastian S; Seksik P; Singh A; So K; Sokol H; Subramaniam K; Todd A; Annese V; Weersma RK; Xavier R; Ward R; Weedon MN; Goodhand JR; Kennedy NA; Ahmad T;
    JAMA; 2019 Feb; 321(8):773-785. PubMed ID: 30806694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonmelanoma Skin Cancer Risk in Patients With Inflammatory Bowel Disease Undergoing Thiopurine Therapy: A Systematic Review of the Literature.
    Hagen JW; Pugliano-Mauro MA
    Dermatol Surg; 2018 Apr; 44(4):469-480. PubMed ID: 29315147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maternal thiopurine metabolism during pregnancy in inflammatory bowel disease and clearance of thiopurine metabolites and outcomes in exposed neonates.
    Flanagan E; Wright EK; Hardikar W; Sparrow MP; Connell WR; Kamm MA; De Cruz P; Brown SJ; Thompson A; Greenway A; Westley I; Barclay M; Ross AL; Kiburg KV; Bell SJ;
    Aliment Pharmacol Ther; 2021 Apr; 53(7):810-820. PubMed ID: 33608894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relapse rates after withdrawal of thiopurines in patients with inflammatory bowel disease.
    Ranjan MK; Vuyyuru SK; Kante B; Kumar P; Mundhra SK; Golla R; Sharma R; Sahni P; Das P; Makharia G; Kedia S; Ahuja V
    Int J Colorectal Dis; 2022 Aug; 37(8):1817-1826. PubMed ID: 35835862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of Biologic Therapy by Pregnant Women With Inflammatory Bowel Disease Does Not Affect Infant Response to Vaccines.
    Beaulieu DB; Ananthakrishnan AN; Martin C; Cohen RD; Kane SV; Mahadevan U
    Clin Gastroenterol Hepatol; 2018 Jan; 16(1):99-105. PubMed ID: 28870657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thiopurine treatment in inflammatory bowel disease: clinical pharmacology and implication of pharmacogenetically guided dosing.
    Teml A; Schaeffeler E; Herrlinger KR; Klotz U; Schwab M
    Clin Pharmacokinet; 2007; 46(3):187-208. PubMed ID: 17328579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Routinely Established Skewed Thiopurine Metabolism Leads to a Strikingly High Rate of Early Therapeutic Failure in Patients With Inflammatory Bowel Disease.
    Kreijne JE; Seinen ML; Wilhelm AJ; Bouma G; Mulder CJ; van Bodegraven AA; de Boer NK
    Ther Drug Monit; 2015 Dec; 37(6):797-804. PubMed ID: 25853923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased risk of thiopurine-related adverse events in elderly patients with IBD.
    Calafat M; Mañosa M; Cañete F; Ricart E; Iglesias E; Calvo M; Rodríguez-Moranta F; Taxonera C; Nos P; Mesonero F; Martín-Arranz MD; Mínguez M; Gisbert JP; García-López S; de Francisco R; Gomollón F; Calvet X; Garcia-Planella E; Rivero M; Martínez-Cadilla J; Argüelles F; Arias L; Cimavilla M; Zabana Y; Domènech E;
    Aliment Pharmacol Ther; 2019 Oct; 50(7):780-788. PubMed ID: 31429097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What Happens to Patients with Inflammatory Bowel Disease Who Are Intolerant to Thiopurines?
    Gensmyr-Singer H; Karling P
    Inflamm Intest Dis; 2024; 9(1):135-146. PubMed ID: 39015258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of thiopurine discontinuation at anti-tumour necrosis factor initiation in inflammatory bowel disease treatment: a nationwide Danish cohort study.
    Thomsen SB; Ungaro RC; Allin KH; Elmahdi R; Poulsen G; Andersson M; Colombel JF; Jess T
    Aliment Pharmacol Ther; 2022 May; 55(9):1128-1138. PubMed ID: 35080036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful Pregnancies with Thiopurine-Allopurinol Co-Therapy for Inflammatory Bowel Disease.
    Sheikh M; Nelson-Piercy C; Duley J; Florin T; Ansari A
    J Crohns Colitis; 2015 Aug; 9(8):680-4. PubMed ID: 25939351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systematic review and meta-analysis on the effects of thiopurines on birth outcomes from female and male patients with inflammatory bowel disease.
    Akbari M; Shah S; Velayos FS; Mahadevan U; Cheifetz AS
    Inflamm Bowel Dis; 2013 Jan; 19(1):15-22. PubMed ID: 22434610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proactive Metabolite Testing in Patients on Thiopurine May Yield Long-Term Clinical Benefits in Inflammatory Bowel Disease.
    Barnes A; Ooi SJ; Lynch KD; Parthasarathy N; Bishara M; Gounder M; Grafton R; Leach P; Bampton P; Sechi A; Ng W; Connor S; van Langenberg D; Mountifield R; Andrews JM
    Dig Dis Sci; 2023 Mar; 68(3):889-896. PubMed ID: 35687221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of lymphoma in patients with ulcerative colitis treated with thiopurines: a nationwide retrospective cohort study.
    Khan N; Abbas AM; Lichtenstein GR; Loftus EV; Bazzano LA
    Gastroenterology; 2013 Nov; 145(5):1007-1015.e3. PubMed ID: 23891975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How I treat my inflammatory bowel disease-patients with thiopurines?
    Meijer B; Mulder CJ; van Bodegraven AA; de Boer NK
    World J Gastrointest Pharmacol Ther; 2016 Nov; 7(4):524-530. PubMed ID: 27867685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.